CTI BioPharma completes private placement of convertible preferred stock

CTI BioPharma Corp. (NASDAQ:CTIC; Milan:CTIC), Seattle, Wash. Business: Cancer, Hematology, Autoimmune Date completed: 2014-11-07 Type: Private placement of convertible preferred stock Raised: $35 mil...